Globe Newswire
Dublin, Jan. 21, 2021 (GLOBE NEWSWIRE) -- The "India Molecular Diagnostics Market By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In-situ Hybridization, Chips and Microarrays, Others), By End User, By Region, Competition, Forecast & Opportunities, FY 2026" report has been added to ResearchAndMarkets.com's offering. The Indian Molecular Diagnostics Market stood at an estimated $920 million in FY 2020 and is projected to grow at a CAGR of around 10% until FY 2026, predominantly on account of rising cases of fatal and chronic diseases. Moreover, spread of COVID-19 pandemic is expected to create more opportunities, which is anticipated to drive the market growth during the forecast period. Furthermore, government initiatives of raising funds for the country's molecular department is also expected to positively influence the market in the coming years. However, since the department requires high competence and professional skillset, absence of the same can pose a hurdle. Also, with over 25% of the country's population being below poverty line and the rest of the population is either middle-class or lower middle-class, lack of funds and high cost of molecular diagnostics is also expected to hinder the growth of the market during the forecast period.The Indian Molecular Diagnostics Market is segmented into application, technology, end-user, and region. Based on application, the market is further fragmented into infectious disease, blood screening, genetic testing and oncology testing, out of which oncology testing segment is expected to dominate the market until FY 2026, followed by the infectious disease segment.Major players operating in the Indian Molecular Diagnostics Market include Roche Diagnostics India Pvt Ltd, Abbott India Limited, Qiagen India Pvt Ltd, bioMerieux India, Becton Dickinson Private Limited, Biocartis, Bio-Techne India Private Limited, Danaher, Bio-Rad laboratories India Pvt.Ltd, Cleaver Scientific, etc.Years considered for this report: Historical Years: FY2016 - FY2019Base Year: FY2020Estimated Year: FY2021Forecast Period: FY2022 - FY2026 Key Topics Covered: 1. Product Overview2. Research Methodology3. Executive Summary4. Voice of Customer5. India Molecular Diagnostics Market Outlook5.1. Market Size & Forecast5.1.1. By Value5.2. Market Share & Forecast5.2.1. By Application (Infectious disease, Blood screening, Genetic testing, Oncology testing)5.2.2. By Technology (PCR, In-situ hybridization, Chips and microarrays, Mass spectrometry, Sequencing, Others)5.2.3. By End User (Hospitals, Academic & Reference Laboratories)5.2.4. By Region (North, East, West, South)5.2.5. By Company (FY2020)5.3. Market Attractiveness Index6. India PCR Technology Based Molecular Diagnostics Market Outlook6.1. Market Size & Forecast6.1.1. By Value6.2. Market Share & Forecast6.2.1. By Application6.2.2. By End User7. India In-Situ Hybridization Molecular Diagnostics Market Outlook7.1. Market Size & Forecast7.1.1. By Value7.2. Market Share & Forecast7.2.1. By Application7.2.2. By End User8. India Chips and microarrays Molecular Diagnostics Market Outlook8.1. Market Size & Forecast8.1.1. By Value8.2. Market Share & Forecast8.2.1. By Application8.2.2. By End User9. India Mass spectrometry Molecular Diagnostics Market Outlook9.1. Market Size & Forecast9.1.1. By Value9.2. Market Share & Forecast9.2.1. By Application9.2.2. By End User10. India Sequencing Molecular Diagnostics Market Outlook10.1. Market Size & Forecast10.1.1. By Value10.2. Market Share & Forecast10.2.1. By Application10.2.2. By Technology10.2.3. By End User11. Market Dynamics11.1. Drivers11.2. Challenges12. Market Trends & Developments13. Policy & Regulatory Landscape14. India Economic Profile15. Competitive Landscape15.1. Competition Outlook15.2. Company Profiles15.2.1. Roche Diagnostics India Pvt Ltd15.2.2. Abbott India Limited15.2.3. Qiagen India Pvt Ltd15.2.4. bioMerieux India Pvt. Ltd.15.2.5. Becton Dickinson Private Limited15.2.6. Biocartis Group15.2.7. Bio-Techne India Private Limited15.2.8. Danaher Corporation15.2.9. Bio-Rad laboratories India Pvt.Ltd15.2.10. Cleaver Scientific16. Strategic Recommendations For more information about this report visit https://www.researchandmarkets.com/r/dvx2xt Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900